DeepMed Research

INSTITUTE OF LIVER AND BILIARY SCIENCES

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed

Not Applicable

Completed

Conditions: Ischemic Hepatitis

Interventions: Drug: Standard Care + NAC (N -ACETYLCYSTEINE)
Drug: Standard Care (in control arm)

First Posted Date: 2013-12-19

Last Posted Date: 2019-09-13

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 220

Registration Number: NCT02015403

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Incidence and Spectrum of Acute Kidney Injury in Cirrhotics and Assessment of New Biomarkers as Early Predictors of Acute Kidney Injury

Completed

Conditions: Acute Kidney Injury

First Posted Date: 2013-12-19

Last Posted Date: 2015-08-13

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 450

Registration Number: NCT02016053

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).

Not Applicable

Completed

Conditions: Acute Liver Failure
Acute on Chronic Liver Failure

Interventions: Device: Methacetin Breath Test in ACLF and ALF patients

First Posted Date: 2013-09-19

Last Posted Date: 2015-09-29

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 24

Registration Number: NCT01946360

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.

Not Applicable

Completed

Conditions: Decompensated Cirrhosis

Interventions: Drug: G-CSF
Drug: G-CSF+Erythropoetin

First Posted Date: 2013-07-18

Last Posted Date: 2016-11-22

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 60

Registration Number: NCT01902511

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure

Completed

Conditions: Cirrhosis
Chronic Liver Failure
Acute Liver Failure

First Posted Date: 2013-06-07

Last Posted Date: 2015-05-27

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 522

Registration Number: NCT01872767

Locations: 🇮🇳
Institute of Liver & Biliary Sciences., New Delhi, Delhi, India

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

Not Applicable

Completed

Conditions: Spontaneous Bacterial Peritonitis

Interventions: Drug: Imipenem + Albumin
Drug: cefepime + Albumin

First Posted Date: 2013-05-14

Last Posted Date: 2016-11-22

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 175

Registration Number: NCT01852630

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit

Not Applicable

Completed

Conditions: Cirrhosis With Septic Shock

Interventions: Drug: Noradrenaline
Drug: Terlipressin

First Posted Date: 2013-04-19

Last Posted Date: 2016-11-22

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 84

Registration Number: NCT01836224

Locations: 🇮🇳
Institute of liver and Biliary Sciences, New Delhi, Delhi, India

Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis

Not Applicable

Completed

Conditions: Severe Alcoholic Hepatitis

Interventions: Drug: Placebo
Drug: G-CSF

First Posted Date: 2013-03-28

Last Posted Date: 2017-11-14

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 28

Registration Number: NCT01820208

Locations: 🇮🇳
Institute of liver and Biliary Sciences, New Delhi, Delhi, India

To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B

Not Applicable

Completed

Conditions: Spontaneous Reactivation of Hepatitis B

Interventions: Drug: Tenofovir
Drug: Tenofovir + Telbivudine

First Posted Date: 2012-11-22

Last Posted Date: 2016-03-23

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 69

Registration Number: NCT01732224

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease

Not Applicable

Conditions: Chronic Liver Disease With Tuberclosis

Interventions: Drug: 9HLE
Drug: 2HRZE/4HR
Drug: 9RLE
Drug: 2HRLE/4HR

First Posted Date: 2012-09-03

Last Posted Date: 2013-12-17

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 120

Registration Number: NCT01677871

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy